Cenomed

Cenomed, Inc., a pharmaceutical company, develops new drug therapies for the treatment of neurological disorders. It provides medications for neurological conditions such as schizophrenia, mild cognitive impairment, memory/attention deficits associated with aging, attention deficit hyperactivity disorder, pain, counter-terrorism, and chemical defense. Cenomed, Inc. was founded in 2003 and is headquartered in Lake Forest, California.